Clinical Research Directory
Browse clinical research sites, groups, and studies.
Addressing Violence in the Context of Opioid Use Disorder Care
Sponsor: Lifespan
Summary
The goal of this clinical trial is to learn if the SHE-OUD program helps women who are receiving buprenorphine treatment for opioid use disorder (OUD), have experienced sexual violence, and have PTSD. The study will examine whether the program is practical to deliver, safe, and acceptable to participants. The main questions it aims to answer are: Is SHE-OUD feasible, acceptable, and satisfying for women in OUD treatment who have experienced sexual violence and have PTSD? Does SHE-OUD increase participants' engagement in mental health treatment for PTSD? The study will first evaluate SHE-OUD in a small open trial, then compare SHE-OUD to a control condition in a randomized trial to see if SHE-OUD increases engagement in mental health treatment. Participants will: complete the SHE-OUD program (or, in the randomized trial, either SHE-OUD or the control condition), continue regular buprenorphine treatment for OUD, complete assessments at the start of the study and at a 1-month follow-up, and answer questions about mental health, treatment engagement, and satisfaction with the program.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-12-05
Completion Date
2027-08-15
Last Updated
2026-11-17
Healthy Volunteers
No
Interventions
SHE-OUD
The SHE-OUD intervention provides screening for sexual victimization and PTSD among individuals seeking MOUD treatment with the goal of enhancing mental health treatment utilization, and enhancing OUD treatment outcomes. Aftereffects of sexual victimization are addressed (i.e., intimate partner violence, substance use) if participants endorse a risk for these concerns. All participants are provided with brief intervention for sexual victimization, PTSD, and the intersection of sexual victimization and OUD.